ClinicalTrials.gov
ClinicalTrials.gov Menu

ADenoVirus Initiative Study in Epidemiology in Spain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02254330
Recruitment Status : Completed
First Posted : October 1, 2014
Last Update Posted : January 10, 2017
Sponsor:
Information provided by (Responsible Party):
NicOx

Brief Summary:
The objectives of this study is to assess the characteristics and frequency of adenovirus conjunctivitis in a population of male and female patients from one year of age who present signs and symptoms of acute conjunctivitis.

Condition or disease
Viral Conjunctivitis

Detailed Description:
Epidemiological, prospective, open, multicentric trial in patients suffering from acute conjunctivitis who will undergo a rapid diagnostic test for adenoviral conjunctivitis at the time of their visit to the ophthalmologist office, at the emergency room or during hospitalization. This epidemiological study will include approximately 500 patients in Spain. The planned duration of the study is one year from the first patient visit to the last patient visit.

Study Type : Observational
Actual Enrollment : 386 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Epidemiological, Prospective, Multicentric, Open Study To Assess The Characteristics And Frequency Of Adenoviral Conjunctivitis As Diagnosed With The Point Of Care AdenoPlus® Test In Patients Suffering From Acute Conjunctivitis
Study Start Date : July 2014
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pinkeye




Primary Outcome Measures :
  1. Frequency of patients with adenovirus conjunctivitis [ Time Frame: During the visit to the ophthalmologist before and just after the AdenoPlus® test done on the same day (one visit) ]
    The percentage of patients with adenovirus conjunctivitis documented by a positive AdenoPlus® test over the tested population of male and female patients who present signs and symptoms of acute conjunctivitis.


Other Outcome Measures:
  1. Seasonality and geographic repartition observed. [ Time Frame: During the visit to the ophthalmologist before and just after the AdenoPlus® test done on the same day (one visit) ]
    The number of patients with adenovirus conjunctivitis who visited the ophthalmologist in spring, summer, autumn and winter and their geographic area (e.g. by hospital, by area).

  2. Clinical profiles of the patients [ Time Frame: During the visit to the ophthalmologist before and just after the AdenoPlus® test done on the same day (one visit) ]
    The percentage of each eye signs and symptoms, the mean duration of the disease for both the patients with positive and negative AdenoPlus® tests, the number or follow-up visit done and the correlation between the initial diagnosis (before AdenoPlus® test results) and the final diagnosis (post AdenoPlus® test results).

  3. Resource utilization during the treatment and evaluation of the costs [ Time Frame: On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s) ]
    Estimation of resource utilized during course of treatment (use of drugs, number of visits done by the patient…), and associated costs (which would be calculated by applying unit costs to resource use).

  4. Patient/parent absenteeism linked to this disease. [ Time Frame: On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s) ]
    Number of days out of work and/or out of school linked to this disease.

  5. Safety assessment [ Time Frame: On day 1: at least once during the single visit to the ophthalmologist and if any also during the follow-up visit(s) ]
    Number of adverse incidents (AIs) and events that are of significant (SEs) reported to Nicox



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any female and male patients from one year of age with signs and symptoms of acute conjunctivitis either seen during ophthalmology consultations or who are in the emergency room or hospitalized, can be enrolled in the study
Criteria

Inclusion Criteria:

  • Male or Female patients of at least one year of age presenting acute (for less than 7 days) conjunctivitis signs and symptoms.
  • Patient or / and legal representative (if patient below 18 years of age) must be able to provide oral consent for the collection and treatment of the questionnaire data.
  • No history of hypersensitivity to corn starch, talcum powder or Dacron (sampling fleece components).

Exclusion Criteria:

  • Current use or having received (within the last 7 days) local antiviral therapies such as povidone iodine or ganciclovir, or topical steroids or immunomodulators such as cyclosporine which may interfere with the test result.
  • Previous enrolment in the present study.
  • Any direct involvement with the study conduct at site or any family link with study site staff.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02254330


Locations
Spain
VISSUM
Alicante, Spain
Clinica Barraquer
Barcelona, Spain
Hospital Clinic
Barcelona, Spain
Instituto de Microcirugía Ocular
Barcelona, Spain
Instituto Clínico Quirúrgico de Oftalmología
Bilbao, Spain
Alcazar de San Juan
Ciudad Real, Spain
Hospital La Arruzafa
Córdoba, Spain
Ocumed Clinica Oftalmologica
Madrid, Spain, 28023
Fundacion Jimenez Diaz
Madrid, Spain
Hospital Clinico San Carlos
Madrid, Spain
Hospital de Villalba
Madrid, Spain
Hospital Infanta Leonor-Vallecas
Madrid, Spain
Hospital La Paz
Madrid, Spain
Hospital Quiron
Madrid, Spain
Hospital Ramon Y Cajal
Madrid, Spain
Hospital Torrejon
Madrid, Spain
Instituto Oftalmologico Fernandez-Vega
Oviedo, Spain
Clinica Universitaria de Navarra
Pamplona, Spain
Hospital Clinico Santiago de Compostela
Santiago de Compostela, Spain
Hospital Universitario de Canarias
Tenerife, Spain
Hospital Clinico
Valencia, Spain
Hospital La Fe
Valencia, Spain
Hospital Clinico de Valladolid
Valladolid, Spain
Instituto Oftalmobiologia Aplicada
Valladolid, Spain
Hospital de Cruces, Baracaldo
Vizcaya, Spain
Sponsors and Collaborators
NicOx
Investigators
Principal Investigator: Jose Manuel Benitez Del Castillo, MD Ocumed Clinica Oftalmologica

Responsible Party: NicOx
ClinicalTrials.gov Identifier: NCT02254330     History of Changes
Other Study ID Numbers: ADVISE Spain
First Posted: October 1, 2014    Key Record Dates
Last Update Posted: January 10, 2017
Last Verified: January 2017

Keywords provided by NicOx:
Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test

Additional relevant MeSH terms:
Conjunctivitis
Conjunctivitis, Viral
Conjunctival Diseases
Eye Diseases
Eye Infections, Viral
Virus Diseases
Eye Infections